Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Enzo Biochem, Inc. (ENZ)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
2.2600+0.0500 (+2.26%)
At close: 04:00PM EDT
2.9000 +0.64 (+28.32%)
After hours: 07:38PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close2.2100
Open2.1700
Bid2.1000 x 800
Ask2.9000 x 1000
Day's Range2.1700 - 2.3200
52 Week Range2.1700 - 4.1500
Volume75,429
Avg. Volume60,423
Market Cap110.083M
Beta (5Y Monthly)0.81
PE Ratio (TTM)376.67
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Near Fair Value
-6% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for ENZ

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Enzo Biochem, Inc.
    Analyst Report: Quest Diagnostics, Inc.Quest Diagnostics is a leading global provider of clinical diagnostic services that help to identify and treat disease and improve healthcare management. The company incorporated in Delaware in 1990; its predecessor companies date back to 1967. Quest is based in Secaucus, New Jersey and employs roughly 49,000 people; the stock is a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    11 days agoArgus Research
View more
Advertisement
Advertisement